NKG2A, which binds the non-classical HLA molecule HLA-E, is expressed by subsets of natural killer (NK) cells, CD8+ T cells and innate T cells and negatively regulates their anti-tumour immune activity [1,2,3]. The gene discussed is KLRC1; the disease is neoplasm.